Raymond James & Associates’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
Other funds holding ONEM
CG
SHG
UOC
OMC
WCMNY
AAM
Raymond James & Associates's ONEM Position: Q3 2022 in Review
Raymond James & Associates sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 12,005 shares — an estimated $94K sold.
Raymond James & Associates first reported a position in ONEM in Q2 2020 and held it in 8 quarters. The position peaked at $1.52M in Q4 2020. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.
- Raymond James & Associates reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
- Raymond James & Associates sold 12,005 1Life Healthcare shares in Q3 2022, an estimated $94K.
- Raymond James & Associates first reported a position in 1Life Healthcare in Q2 2020 and held it in 8 quarters.
- Raymond James & Associates's 1Life Healthcare position peaked at $1.52M in Q4 2020.
- 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.
Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.